Novo Path
Disposable Endotracheal Tube for Ventilated Patients
Company Overview
Snapshot
Founded in January 2012 by Arie Ben Josef, Novo Path operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its flagship product, the NovoPath, a disposable endotracheal tube lining.
Business overview
Novo Path is a Health Tech & Life Sciences company focused on developing preventive airway management solutions to minimize complications for mechanically ventilated patients. The company's core product, the NovoPath, a disposable endotracheal tube (ETT) lining, is designed for instant replacement of the ETT's inner surface, preventing the accumulation of bacteria, fungi, and other bioburden. Novo Path operates within the Medical Devices and Life Support sectors, targeting healthcare providers in the healthcare industry.
Log in to access full profile ›Company Intelligence Q&A
- What is Novo Path's primary product?
- Novo Path is developing the NovoPath, a disposable endotracheal tube (ETT) lining that allows for instant replacement of the ETT's inner surface to prevent the accumulation of bacteria, fungi, and other bioburden.
- When was Novo Path founded?
- Novo Path was founded in January 2012.
- Who is the founder of Novo Path?
- Arie Ben Josef is the founder of Novo Path.
- What is Novo Path's primary business model?
- Novo Path operates with a B2B business model.
- What is Novo Path's current product development stage?
- Novo Path's product, the NovoPath, is currently in the Research and Development (R&D) stage, focusing on the development of its disposable endotracheal tube lining.